ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Debt / NOTE 1.000% 9/1
Principal, excl. options Q2 2024
743M
Holdings value Q2 2024
$804M
Value change Q2 2024
-$143M
Grand Portfolio weight change Q2 2024
0%
Number of holders
63
Number of buys Q2 2024
6
Number of sells Q2 2024
-3
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $19.6M $22.9M -$2.34M $1.17 7
2024 Q2 $743M $804M -$143M $1.08 63
2024 Q1 $885M $835M +$37.6M $0.94 67
2023 Q4 $852M $845M +$21.2M $0.99 65
2023 Q3 $847M $790M +$790M $0.93 54